ClinConnect ClinConnect Logo
Search / Trial NCT01788410

MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine

Launched by BRIGHAM AND WOMEN'S HOSPITAL · Feb 7, 2013

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Cryoablation Nerves Facet Joint Pain Neuralgia Neuropathy Image Guided

ClinConnect Summary

This clinical trial is studying a new treatment method called MRI-guided cryoablation, which aims to relieve pain for patients suffering from facet joint disease or nerve pain in the head and neck. The goal is to provide better and longer-lasting pain relief compared to current treatments. Participants in this study will receive a minimally invasive procedure that uses advanced imaging technology to ensure accuracy and safety.

To be eligible for this trial, participants must be at least 18 years old and able to sign a consent form. They should have specific types of pain related to facet joint issues or nerve compression that could benefit from this procedure. Additionally, participants need to be able to attend scheduled visits for imaging before and after the treatment. The study is open to all genders, but pregnant or breastfeeding women cannot participate, and individuals with certain health conditions that affect MRI safety will also be excluded. If you or someone you know is experiencing persistent pain in these areas, this trial could be an option worth considering for improved relief.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants must be willing and able to sign a written informed consent document.
  • Patients must have facet joint disease or pain due to a damaged or compressed nerve that would benefit from a minimally invasive image-guided procedure (i.e., adjacent to critical structures, better visualized under 3 Tesla MRI than CT)
  • Subjects must be able to adhere to the visit schedules and attend pre and post imaging.
  • Participants must be at least 18 years of age
  • Participants must have an estimated life expectancy of \>8 weeks in the opinion of the clinician.
  • Patients with radiculopathy must have the cause of pain confirmed by a nerve block within 3 months prior to ablation
  • Exclusion Criteria:
  • Contraindications to MRI and Gadolinium- (i.e. estimated Glomerular Filtration Rate \<60ml/min, metal clips)
  • Pregnant or breastfeeding woman are excluded from this research.

About Brigham And Women's Hospital

Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.

Locations

Boston, Massachusetts, United States

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Thomas C Lee, MD

Principal Investigator

Brigham and Women's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials